About
About Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides toothache relief drops; parsnicillin tablets, compound amino acid vitamin capsules, compound chlorhexidine dexamethasone, nasal and mouth cleansing spray, constipation relief capsules, anwei tablets, motherwort paste, gynecological menstrual regulating tablets, Sangju cold tablets, hawthorn granules, isatis root granules, col and cough syrup, and gastritis relief granules, as well as acetaminophen, caffeine, and flavoxate tablets. The companys products are used for therapeutic areas such as anti-tumor, cold and cough relief, cardiovascular and cerebrovascular diseases, rheumatic bone pain, antifungal, tonifying and calming mind, and gynecological diseases. In addition, it is involved in wholesale and retail trade, and culture and art businesses; provision of software and information technology services. It also exports its products. The company was founded in 1992 and is based in Shanghai, China.
Research context
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.
From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd's total revenue sank by 3.9% to $490M since the same quarter in the previous year.
Its net income has dropped by 792.8% to $-175M since the same quarter in the previous year.
Finally, its free cash flow fell by 125.2% to $-7M since the same quarter in the previous year.
Based on the above factors, Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd gets an overall score of 2/5.